Compare BlackRock TCP Capital Corp (TCPC) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BlackRock TCP Capital Corp vs 10X Genomics Inc — how do they compare? BlackRock TCP Capital Corp trades at $3.24 (market cap $270.17M), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: 10X Genomics Inc is far larger — about 20.3× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays a 26.09% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TCPC | TXG | |
|---|---|---|
Market Cap | $270.17M | $5.48B |
Sector | Financials | Health |
52-Week High | $7.64 | $45.80 |
52-Week Low | $3.14 | $11.34 |
Dividend Yield | 26.09% | — |
Enterprise Value | — | $5.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BlackRock TCP Capital Corp
BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
